Use of statins and the subsequent development of deep vein thrombosis
about
sameAs
Statins for primary prevention of venous thromboembolismStatins for primary prevention of venous thromboembolismStatins for prevention of venous thromboembolismPrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThe role of dyslipidemia and statins in venous thromboembolismStatins, inflammation and deep vein thrombosis: a systematic reviewThe epidemiology of venous thromboembolismStatins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control studyCholinesterase inhibitors and hospitalization for bradycardia: a population-based studyEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsAtorvastatin-related thrombocytopenic purpura.Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseC-reactive protein and venous thromboembolism: causal or casual association?Antipsychotics and risk of venous thromboembolism: A population-based case-control studyStatins and venous thrombosis: a story too good to be true?Why might statins prevent venous thromboembolism: what needs to be done to know more?The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.Recent trends in lipid management: raising the bar and shifting the goalposts?Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapyStatins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyHigh-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study.Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control studySocioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.Treatment of dyslipidemia in the elderly.Dyslipidemia and lipid-lowering therapy in the elderly.Venous thromboembolism: disease burden, outcomes and risk factors.Venous thromboembolism and atherosclerosis: common denominators or different diseases?Lipid-lowering therapy and outcomes in heart failure.Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.A randomized trial of rosuvastatin in the prevention of venous thromboembolism.Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort studyReversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway.Effect of statins therapy prior to percutaneous coronary intervention.Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.Statins for the prevention of venous thromboembolism? a narrative review.Perioperative statin therapy.Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
P2860
Q24187238-84B50BBD-C5EE-4E42-B0DA-B713D60EE2E9Q24204040-0356CF01-F49C-4064-BFCC-30E7A30BA2FBQ24241510-0FAEF5E5-DBC1-4D33-93C8-CDF7277100B4Q24633010-BF9D60BC-BDD3-40BA-BEEC-95FAFF1FB50EQ24793360-2DA766A5-8EDE-440D-AB3F-675D82838530Q27027545-D52C9549-000C-4C2F-9E37-B018CF6B908DQ28067893-EC7F67BE-D187-49B0-815A-9A650B920CFCQ28211027-416B8CDF-F4E9-4ACB-8A24-0B12351F65B6Q28476190-8A47DCBA-C2EC-4F37-96AC-F2B76D3D2834Q28483807-117800EA-E5ED-4799-8FDE-8E917752E495Q33402096-67938E10-3E8E-44AC-B5B9-5B9851FC28D9Q33826794-1E060372-F397-41F2-86A1-ADFE7A9DB515Q33867311-D0701B56-64FB-486F-9A18-C18074D6A2D2Q34130906-FB90E7B5-582A-4EBA-80AB-2D75394B27B4Q34143987-DB5EF519-706A-4EEF-99CA-902850F6884FQ34426285-EDE50E30-8960-4C28-BE73-9E5D03166DFBQ35001052-FD32DD00-F7EF-47D7-A6D5-FCF62DC85DEDQ35037358-1686D4B7-669A-48CC-8EBB-0FEC45A3785EQ35072212-C8A553D6-2B1D-4448-B331-4A3C0FFA7C30Q35101273-172E0BC8-986D-45F2-BAA2-0534639523BEQ35128843-CEA982F5-4D5A-407F-9A99-CE0F427C5BDAQ35143506-50E8BB23-F515-4DF8-A791-36AAF8D170AAQ35553528-28ACD1EC-E085-42C6-8260-CDEBA000B438Q35624965-2F1075B1-9FE4-40DF-8F0A-C3EC47C0E3DCQ35827218-7F6299E4-31B9-4E32-A187-AE2C811A5C00Q36077229-6FE4C15A-BFE2-4F85-8D4A-C738E6684703Q36124897-4FA7B9E2-9F9B-4349-8B14-78582EABFC6EQ36230821-3EFC1F94-117B-4C03-988E-DE4336882829Q36589318-9977CA3E-4B9E-4225-BFD0-798CAF57FC4FQ36818242-F6115756-7EC3-4D1B-9CFA-C2DAA44AA4CEQ37156292-33445F24-B1F2-4CA2-B90E-F397689AE82CQ37262627-F00CC2A3-BE2F-481B-B094-5335F04A9F75Q37293275-8F81AE7B-2296-430D-AF09-71ACE70BAC2FQ37377564-334776C8-F5A9-48A9-B7C1-51B5CCC787BBQ37976137-930FDC31-9466-4B69-9493-8C5D8DAC396CQ37996577-3CBECD7F-4870-4102-8856-299EB8B83046Q38053889-83A09A0B-362C-48C8-BDD8-99FEA53245E6Q38092149-9DB6E865-EA8E-47DD-B456-2865D6454280Q38211112-DA5934D8-A5A7-40DD-B980-04F012C71D6AQ38471162-53CACEB4-A21B-4920-B08B-1F9FCF5FABAE
P2860
Use of statins and the subsequent development of deep vein thrombosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Use of statins and the subsequent development of deep vein thrombosis
@ast
Use of statins and the subsequent development of deep vein thrombosis
@en
Use of statins and the subsequent development of deep vein thrombosis
@nl
type
label
Use of statins and the subsequent development of deep vein thrombosis
@ast
Use of statins and the subsequent development of deep vein thrombosis
@en
Use of statins and the subsequent development of deep vein thrombosis
@nl
prefLabel
Use of statins and the subsequent development of deep vein thrombosis
@ast
Use of statins and the subsequent development of deep vein thrombosis
@en
Use of statins and the subsequent development of deep vein thrombosis
@nl
P2093
P1476
Use of statins and the subsequent development of deep vein thrombosis
@en
P2093
P304
P356
10.1001/ARCHINTE.161.11.1405
P407
P577
2001-06-11T00:00:00Z